Zhaotao Wang

Guangzhou, 510260, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration.

PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration.

Journal: Cell death & disease

Published: April 16, 2024

Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas.

Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas.

Journal: Scientific reports

Published: April 15, 2024

GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.

GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.

Journal: Aging

Published: April 18, 2023

Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.

Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas.

Journal: Aging

Published: February 13, 2023

Lipidomics of the erythrocyte membrane and network pharmacology to explore the mechanism of mangiferin from Anemarrhenae rhizoma in treating type 2 diabetes mellitus rats.

Lipidomics of the erythrocyte membrane and network pharmacology to explore the mechanism of mangiferin from Anemarrhenae rhizoma in treating type 2 diabetes mellitus rats.

Journal: Journal of pharmaceutical and biomedical analysis

Published: January 20, 2023

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma.

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma.

Journal: BMC cancer

Published: January 16, 2023

PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B.

PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B.

Journal: Oncogene

Published: October 14, 2022

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate.

Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate.

Journal: Frontiers in genetics

Published: December 24, 2021

Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).

Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).

Journal: European journal of pharmacology

Published: December 02, 2021

Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation.

Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation.

Journal: Frontiers in oncology

Published: September 29, 2021

3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells.

3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells.

Journal: Journal of Cancer

Published: August 31, 2021

Hsa_circ_0076931 suppresses malignant biological properties, down-regulates miR-6760-3p through direct binding, and up-regulates CCBE1 in glioma.

Hsa_circ_0076931 suppresses malignant biological properties, down-regulates miR-6760-3p through direct binding, and up-regulates CCBE1 in glioma.

Journal: Bioscience reports

Published: August 17, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026